Improved EFS of patients with T-lineage ALL in the context of contemporary intensive chemotherapy programs. EFS for the entire cohort of patients with T-lineage and B-lineage ALL treated on the 1800 series and 100 series of CCG studies are shown. EFS values at designated points in follow-up are given in the text.